Welcome to our dedicated page for Edgewell Pers Care Co SEC filings (Ticker: EPC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Schick razors and Banana Boat sunscreen share the same parent—Edgewell Personal Care. That broad portfolio means its SEC disclosures cover everything from razor-blade innovation cycles to seasonal sun-care inventories, making a single 10-K feel like three companies in one. If you have ever searched “Edgewell Personal Care SEC filings explained simply,” you already know the challenge.
Our platform turns that sprawl into clarity. AI-powered summaries translate the 250-page Edgewell Personal Care annual report 10-K simplified, highlight segment sales for Wet Shave, Sun & Skin, and Feminine Care, and flag risk factors such as resin cost inflation. Need the latest “Edgewell Personal Care quarterly earnings report 10-Q filing”? It appears here seconds after hitting EDGAR, paired with plain-English revenue bridges and cash-flow walk-throughs. Material announcements are covered too—see “Edgewell Personal Care 8-K material events explained” for recalls or leadership changes.
Many professionals focus on insider moves. Track “Edgewell Personal Care insider trading Form 4 transactions” in real time, spot patterns before new product launches, or drill into “Edgewell Personal Care executive stock transactions Form 4.” You can also compare compensation targets through the “Edgewell Personal Care proxy statement executive compensation” link. Whether you monitor margin pressure, follow ESG metrics, or simply want “understanding Edgewell Personal Care SEC documents with AI,” every filing type—10-K, 10-Q, 8-K, S-8, and more—is updated continuously and distilled into the insights that matter.
American Century entities filed a Schedule 13G/A reporting beneficial ownership in Edgewell Personal Care (EPC).
American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research each report 3,950,190 shares, representing 8.5% of Edgewell’s common stock, with sole voting power 3,808,819 and sole dispositive power 3,950,190 as of 09/30/2025. American Century Capital Portfolios, Inc. reports 2,488,777 shares or 5.4%, with sole voting and dispositive power over the same amount.
The filers certify the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
Edgewell Personal Care Company furnished an update on its business, announcing financial and operating results for its fourth quarter and fiscal year ended September 30, 2025. The results were disclosed via a press release attached as Exhibit 99.1.
The company noted the information was provided under Item 2.02 and is being furnished, not deemed filed under Section 18 of the Exchange Act, and will not be incorporated by reference into other filings except as expressly stated. The press release was issued on November 13, 2025.
Edgewell Personal Care Company (EPC) entered into an Asset Purchase Agreement to sell its Feminine Care segment to Essity for $340 million in cash, subject to customary adjustments for inventory, indebtedness and other items.
Closing is subject to customary conditions, including required approvals under the HSR Act, no legal restraints, accuracy of representations and warranties, and compliance with covenants. Buyer-specific conditions include no material adverse effect on the business, no ongoing substantial destruction of manufacturing facilities, and certain third‑party consents.
The agreement includes customary termination rights if the deal is not completed by May 12, 2026, with automatic extensions to August 12, 2026 and November 12, 2026 if specified regulatory approvals remain outstanding. The Company may receive a $15 million termination fee from the Buyer under certain circumstances tied to regulatory efforts. The parties expect to enter a transition services agreement at closing.
Edgewell Personal Care (EPC) reported insider transactions by its Chief Supply Chain Officer reflecting RSU vesting and tax withholding over three days. On 11/08/2025, 4,425 shares were acquired at $0 via the conversion of restricted stock equivalents, with 2,051 shares withheld for taxes at $18.83. On 11/10/2025, 2,046 shares were acquired at $0 and 949 shares were withheld at $18.83. On 11/11/2025, 1,635 shares were acquired at $0 and 758 shares were withheld at $18.57.
Following these transactions, direct ownership stood at 43,242.693 shares. The filing notes these were conversions of restricted stock equivalents and that shares were withheld to cover tax liabilities upon vesting.
Edgewell Personal Care (EPC): Chief People & Legal Officer LaTanya Langley reported routine equity award activity. Restricted stock equivalents vested and converted into common stock on three dates: 3,688 shares on 11/08/2025, 2,338 shares on 11/10/2025, and 1,635 shares on 11/11/2025, each at an exercise price of $0.
To cover taxes upon vesting, shares were withheld: 1,835 at $18.83 on 11/08/2025, 1,164 at $18.83 on 11/10/2025, and 814 at $18.57 on 11/11/2025. Following these transactions, the officer directly owned 16,767 shares.
Edgewell Personal Care (EPC) reported an insider transaction by its Chief Accounting Officer. On 11/08/2025, 461 shares of common stock were acquired at $0 upon the vesting and conversion of restricted stock equivalents (code M). To cover taxes, 128 shares were withheld at $18.83 (code F).
Following these transactions, the officer directly owns 333 shares of EPC common stock. Derivative holdings consist of 922 restricted stock equivalents after the reported activity.
Edgewell Personal Care (EPC) CEO and director Rod R. Little reported multiple equity transactions. On 11/08/2025, 11/10/2025, and 11/11/2025, restricted stock equivalents vested and converted to common stock (codes M) for 17,285, 14,612, and 12,578 shares at $0, respectively.
To cover taxes on these vestings (code F), shares were withheld: 8,012 at $18.83 on 11/08/2025, 6,773 at $18.83 on 11/10/2025, and 5,830 at $18.57 on 11/11/2025. Following these transactions, Mr. Little beneficially owned 334,373 shares directly.
Edgewell Personal Care (EPC) CFO reported routine equity transactions on Form 4 tied to restricted stock equivalents vesting. On 11/10/2025, 1,023 shares of common stock were acquired at $0 upon vesting, followed by 356 shares withheld at $18.83 to cover taxes. On 11/11/2025, an additional 780 shares vested at $0, with 272 shares withheld at $18.57 for taxes.
Following these transactions, the CFO directly holds 25,740 shares of EPC common stock. The filing labels the acquisitions as code “M” (conversion of derivative securities) and the withholdings as code “F” (tax withholding), consistent with standard equity award vesting mechanics.
Edgewell Personal Care (EPC): Form 4 insider activity
Officer Jessica Spence, President, North America, reported the vesting and conversion of 4,425 restricted stock equivalents into EPC common stock on 11/08/2025 (Code M) at an exercise price of $0. To satisfy tax obligations, 2,390 shares were withheld (Code F) at a price of $18.83.
Following these transactions, the reporting person directly owns 2,035 shares of EPC common stock. The filing also lists 8,850 derivative securities (restricted stock equivalents) beneficially owned after the reported activity.
Edgewell Personal Care insider filing shows executive departure and resulting equity changes. The Form 4 reports that Daniel Sullivan, the company's Chief Operating Officer, departed on October 1, 2025, triggering the disposition and forfeiture of equity awards. The filing records a disposition of 90,418 shares of common stock and notes that several unvested awards were forfeited upon departure. The form also lists multiple vested stock options and restricted stock equivalents that remained exercisable or convertible after departure, with holders typically having 90 days to exercise vested options. The filing is signed by an attorney-in-fact on October 2, 2025 and includes detailed counts and exercise prices for each option and award.
FAQ
What is the current stock price of Edgewell Pers Care Co (EPC)?
What is the market cap of Edgewell Pers Care Co (EPC)?
